Erratum: Anticancer activity of pyrazole via different biological mechanisms (Synthetic Communications, (2016), 44, 10, (1333-1374) 10.1080/00397911.2013.837186);Anticancer activity of pyrazole via different biological mechanisms

Synthetic Communications

Volumn 44, Issue 10, 2014, Pages 1333-1374

  Chauhan, Simpal ^a   Paliwal, Sarvesh ^a   Chauhan, Rajani ^a  

^a BANASTHALI UNIVERSITY   (India)

Author keywords

Enantiomers; imatinib resistant mutations; lipoxygenases; promyelecytic; resorcinylic; rofecoxib

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; AURORA A KINASE; AURORA B KINASE; AURORA C KINASE; AURORA KINASE INHIBITOR; BCR ABL PROTEIN; CISPLATIN; CYCLIN DEPENDENT KINASE INHIBITOR; CYTOTOXIC AGENT; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; FLUORO[3,2 C]PYRAZOLE; GELDANAMYCIN; HEAT SHOCK PROTEIN; IMATINIB; LYPOOXYGENASE INHIBITOR; MITOXANTRONE; POLO LIKE KINASE 1; POLO LIKE KINASE INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; PYRAZOLE DERIVATIVE; TALLIMUSTINE; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; CANCER INHIBITION; CYTOTOXICITY; DNA BINDING; DRUG MECHANISM; HUMAN; NONHUMAN; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 84899734727     PISSN: 00397911     EISSN: 15322432     Source Type: Journal    
DOI: 10.1080/00397911.2016.1193339     Document Type: Erratum

References (114)

1. Jamel, A.; Siegel, R.; Xu, J.; Ward, E. Cancer J. Clin. 2010, 60, 277.
2. Frankish, H. Lancet 2003, 361, 1278.
3. Daidone, G.; Maggio, B.; Raffa, D.; et al. Farmaco 2004, 59(5), 413.
4. Chou, L.-C.; Huang, L.-J.; Yang, J.-S.; et al. Bioorg. Med. Chem. 2007, 15, 1732.
5. Baraldi, P. G.; Beria, I.; Cozzi, P.; et al. Bio. Med. Chem. 2004, 12, 3911.
6. Burja, B.; Cimbora, Z. T.; Tomic, S.; et al. Bio. Med. Chem. 2010, 18, 2375.
7. Schenone, S.; Bruno, O.; Ranise, A.; et al. Bioorg. Med. Chem. Lett. 2004, 14, 2511.
8. Daidone, G.; Raffa, D.; Maggio, B.; et al. Eur. J. Med. Chem. 2004, 39, 219.
9. Christodoulou, M. S.; Liekens, S.; Kasiotis, K. M.; et al. Bioorg. Med. Chem. 2010, 18(12), 4338.
10. Raju, M.; Chandrappa, S.; Ramakrishna, M. K.; et al. J. Cancer Therapy 2010, 1, 1.
11. Pier, G. B.; Mojgan, T. A.; Delia, P.; et al. Pure Appl. Chem. 2003, 75(2-3), 187.
12. Zheng, L. W.; Ge, Y.; Li, D.; Zhao, B. X.; et al. Bioorg. Med. Chem. Lett. 2010, 20(16), 4766.
13. Ding, X. L.; Zhang, H. Y.; Qi, L.; et al. Bioorg. Med. Chem. Lett. 2009, 19(18), 5325.
14. Lian, S.; Su, H.; Zhao, B. X. Bioorg. Med. Chem. 2009, 17(20), 7085.
15. Burja, B.; Cimbora-Zovko, T.; Tomic, S.; et al. Bioorg. Med. Chem. 2010, 18(7), 2375.
16. Pevarello, P.; Brasca, M. G.; Amici, R.; et al. J. Med. Chem. 2004, 47, 3367.
17. Pevarello, P.; Brasca, M. G.; Amici, R.; et al. J. Med. Chem. 2005, 48, 2944.
18. Krystof, V.; Cankar, P.; Frysova, I.; et al. J. Med. Chem. 2006, 49, 6500.
19. Soncini, C.; Carpinelli, P.; Gianellini, L.; et al. Clin. Cancer Res. 2006, 12(13), 4080-4089.
20. Fancelli, D.; Moll, J.; Varasi, M.; et al. J. Med. Chem. 2006, 49, 7247.
21. Cheung, K. M.; Matthews, T. P.; James, K.; et al. Biorg. Med. Chem. Lett. 2005, 15, 3338.
22. Dymock, B. W.; Barril, X.; Brough, P. A.; et al. J. Med. Chem. 2005, 48, 4212.
23. Beria, D.; Ballinari, J. A.; Bertrand, D.; et al. J. Med. Chem. 2010, 53, 3532.
24. Wasylyk, C.; Zheng, H.; Castell, C.; et al. Cancer Res. 2008, 68, 1275.
25. Dhara, P.; Maulik, P. S.; Vipul, P.; et al. Int. J. Pharm. Sci. Drug Res. 2010, 2(2), 80.
26. Rajashree, P.; Prafulla, B. C.; Manish, S. B.; et al. Asian J. Biochem. Pharm. Res. 2012, 2(1), 352.
27. Sawyer, J. S.; Beight, D. W.; Britt, K. S.; et al. Bioorg. Med. Chem. Lett. 2004, 14(13), 3581.
28. Sammes, P. G. Topics in Antibiotic Chemistry; John Wiley and Sons: New York, 1982; p. 189.
29. Hanahan, D.; Weinberg, R. A. Cell 2000, 100, 57-70
30. Malumbres, M.; Barbacid, M. Nat. Rev. Cancer 2001, 1, 222.
31. Grana, X.; Reddy, E. P. Oncogene 1995, 11, 211
32. Christian, B. A.; Grever, M. R.; Byrd, J. C.; et al. Curr. Opin. Oncol. 2007, 19, 573.
33. Fuse, E.; Kuwabara, T.; Sparreboom, A.; et al. J. Clin. Pharm. 2005, 45, 394.
34. Misra, R. N.; Xiao, H.; Kim, K. S.; et al. J. Med. Chem. 2004, 47, 1719.
35. Meijer, L.; Bettayeb, K.; Galons, H. Roscovitine (CYC202, seliciclib). In Monographs on Enzyme Inhibitors, CDK Inhibitors and Their Potential as Anti-Tumor Agents. CRC Press: Boca Raton, FL, 2007; pp. 187-266.
36. Toogood, P. L.; Harvey, P. J.; Repine, J. T.; et al. J. Med. Chem. 2005, 48, 2388.
37. Tetsu, O.; McCormick, F. Cancer Cell 2003, 3, 233
38. Martin, A.; Odajima, J.; Hunt, S. L.; et al. Cancer Cell 2005, 7, 591
39. Hirai, H.; Kawanishi, N.; Iwasawa, Y. Curr. Top. Med. Chem. 2005, 5, 167.
40. Ibrahim, D. A.; Ismail, N. S. Eur. J. Med. Chem. 2011, 46(12), 5825.
41. Alessio, R. D.; Bargiotti, A.; Metz, S.; et al. Bioorg. Med. Chem. Lett. 2005, 15, 1315.
42. Brasca, M. G.; Amboldi, N.; Ballinari, D. J.; et al. Med. Chem. 2009, 52, 5152.
43. Traquandi, G.; Brasca, M. G.; Alessio, R. D.; et al. WO Patent 2004=104007, 2004.
44. Noskova, V.; Dzubak, P.; Kuzmina, G.; et al. Neoplasma 2002, 49, 418.
45. Gucky, T.; Rezníckova, E.; Dzubak, P.; et al. ChemInform 2010, 41(41), 709.
46. Cho, Y. S.; Borland, M.; Brain, C.; et al. J. Med. Chem. 2010, 51, 7938.
47. Keen, N.; Taylor, S. Nat. Rev. Cancer 2004, 4, 927.
48. Fancelli, D.; Berta, D.; Bindi, S.; et al. J. Med. Chem. 2005, 48(8), 3080.
49. Soncini, C.; Carpinelli, P.; Gianellini, L.; et al. Clin. Cancer Res. 2006, 12(13), 4080.
50. Fancelli, D.; Moll, J.; Varasi, M.; et al. J. Med. Chem. 2006, 49, 7247-725.
51. Mortlock, K. M.; Foote, N. M.; Heron, F. H.; et al. J. Med. Chem. 2007, 50, 2213.
52. Rawson, T. E.; Ruth, M.; Blackwood, E.; et al. J. Med. Chem. 2008, 51, 4465.
53. Prime, M. E.; Courtney, S. M.; Brookfield, P. A.; et al. J. Med. Chem. 2011, 54, 312.
54. An, A.; Tiwari, A.; Sun, Y.; et al. Leukemia Res. 2010, 34(10), 1255.
55. Weisberg, E.; Manley, P. W.; Cowan-Jacob, S. W.; et al. Nat. Rev. 2007, 7, 345.
56. Xiaomei, R.; Xiaofen, P.; Zhang, Z.; et al. J. Med. Chem. 2013, 56, 879.
57. Manetti, F.; Brullo, C.; Magnani, M.; et al. J. Med. Chem. 2008, 51, 1252.
58. Schulte, T. W.; Neckers, L. M. Cancer Chemother. Pharmacol. 1998, 42, 273.
59. Goetz, M. P.; Toft, D.; Reid, J.; et al. J. Clin. Oncol. 2005, 23, 1078.
60. Brough, X.; Barril, M.; Beswick, B.; et al. Bioorg. Med. Chem. Lett. 2005, 15(23), 5197.
61. Schöffski, P. Oncologist 2009, 14, 559.
62. Chopra, P.; Sethi, G.; Dastidar, S. G.; et al. Expert Opin. Investig. Drugs 2010, 19(1), 27.
63. Barr, F. A.; Sillje, H. H.; Nigg, E. A. Nat. Rev. Mol. Cell Biol. 2004, 5, 429.
64. Van Vugt, M. A.; Van de Weerdt, B. C.; Vader, G.; et al. J. Biol. Chem. 2004, 279, 36841.
65. Nakajima, H.; Toyoshima-Morimoto, F.; Taniguchi, E.; et al. J. Biol. Chem. 2003, 278, 25277.
66. Wolf, G.; Elez, R.; Doermer, A.; et al. Oncogene 1997, 14, 543.
67. Weichert, W.; Schmidt, M.; Gekeler, V.; et al. Prostate 2004, 60, 240.
68. Weichert, W.; Denkert, C.; Schmidt, M.; et al. Br. J. Cancer 2004, 90, 815.
69. Weichert, W.; Kristiansen, G.; Winzer, K. J.; et al. Virchows Archiv. 2005, 446, 442.
70. Schmit, T. L.; Zhong, W.; Setaluri, V.; et al. J. Invest. Dermatol. 2009, 129, 2843.
71. Knecht, R.; Elez, R.; Oechler, M.; et al. Cancer Res. 1999, 59, 2794.
72. Nogawa, M.; Yuasa, T.; Kimura, S.; et al. J. Clin. Invest. 2005, 115, 978.
73. Barbey, S.; Goossens, L.; Taverne, T.; et al. Bioorg. Med. Chem. Lett. 2002, 12, 779.
74. Pommery, N.; Taverne, T.; Telliez, A.; Goosesense, L.; Charlie, C.; Pommery, N.; Goossens, J.; Houssin, J. F.; Durant, F.; Henichart, J. P. J. Med. Chem. 2004, 47, 6195.
75. Fortunato, T. G. N. Engl. J. Med. 2008, 358, 1160.
76. Lv, P. C.; Li, H. Q.; Sun, J. Bioorg. Med. Chem. 2010, 18, 4606.
77. Hong, Z.; Christine, W.; Abdelkader, A.; et al. Genes Develop. 2003, 17, 2283.
78. Koji, N.; Hong, G. G. Z.; Gilles, B.; et al. Oncogene 2005, 24(5), 820.
79. Wasylyk, C.; Zheng, H.; Castell, C.; et al. Cancer Res. 2008, 68(5), 1275.
80. Franchini, M. C.; Bonini, B. F.; Camaggi, C. M.; et al. Eur. J. Med. Chem. 2010, 45, 2024.
81. Rostom, S. A. F.; Shalaby, M. A.; El-Demellawy, M. A. Eur. J. Med. Chem. 2003, 38, 959.
82. Al-Saadi, M. S. M.; Rostom, S. A. F.; Faid Allah, H. M. Saudi Pharm. J. 2005, 13, 89.
83. Riyadh, S. M. Molecules 2011, 16, 1834.
84. Rostam, S. A. F. Bioorg. Med. Chem. 2010, 18, 2767.
85. Bandgar, P.; Totre, J. V.; Gawande, S. S.; et al. Bioorg. Med. Chem. 2010, 18, 6149.
86. Christodoulou, M. S.; Liekens, S.;Kasiotis, K. M.; et al. Bioorg. Med. Chem. 2010, 18, 4338.
87. Raju, H.; Chandrappa, S.; Ramkrishna, M. K.; Nagamani, T. S.; et al. J. Cancer Ther. 2010, 1, 1.
88. Primofiore, G.; Marini, A. M.; Salerno, S.; et al. J. Heterocycl. Chem. 2005, 42, 1357.
89. Klirajan, R.; Rathore, L.; Juble, S.; et al. Indian J. Educ. Res. 2010, 44(4), 356.
90. Congiu, V.; Onnis, L.; Vesci, M.; et al. Bioorg. Med. Chem. 2010, 17(1), 6238.
91. Chun, Y. S.; Yeo, E. J.; Park, J. W. Cancer Lett. 2004, 207, 1.
92. Yeo, J.; Chun, Y. S.; Kim, J.; et al. J. Natl. Cancer Inst. 2003, 95, 516.
93. Chou, L.-C.; Huang, L.-J.; Hsu, M.-H.; et al. Eur. J. Med. Chem. 2010, 45, 1395.
94. Magd-El-Din, Abd-El-All, A. S.; Roaiah, H. A. M.; et al. J. Ame. Sci. 2010, 6(5), 251.
95. Magd-El-Din, A. S.; Abd-El-All, A. H.; Abdel-Rhaman, M. M. S.; et al. Nat. Sci. 2010, 8(9), 12.
96. Wang, X.-K.; Liang, Y. J.; et al. Chin. J. Cancer 2010, 29(12), 1982.
97. Fabio, P.; Annalisa, N.; Antonella, S.; et al. J. Med. Chem. 2004, 47(7), 1595.
98. Sunil, D.; Isloor, A. M.; Shetty, P. Pharm. Chem. 2009, 1(2), 19.
99. Via, L. D.; Murine, A. M.; Salerno, S.; et al. Bioorg. Med. Chem. 2009, 17, 328.
100. Medina, J. C.; Roch, D.; Shan, B.; et al. Bioorg. Med. Chem. Lett. 1999, 9, 1843.
101. Al-Saadi, M. S. M. Saudi Pharmaceut. J, 2008, 16(2), 135.
102. Rosenberg, L.; VanCamp, J. E.; Trosko, V. H.; et al. Nature 1969, 222, 385.
103. Keter, F. K.; Kanyanda, S.; Lyantagaye, S. S. L.; et al. Cancer Chemother. Pharmacol. 2008, 63, 127.
104. Natto, H.; Ohsuki, S.; Sugimor, M.; et al. Chem. Pharm. Bull. 1999, 47(12), 1679.
105. Natto, H.; Ohsuki, S.; Sugimor, M.; et al. Chem. Pharm. Bull. 2002, 50(4), 453.
106. Natto, H.; Ohsuki, S.; Sugimor, M.; et al. Chem. Pharm. Bull. 2005, 53(2), 153.
107. Abadi, H.; Eissa, A. A. H.; Hassan, G. S. Chem. Pharm. Bull. 2003, 51, 838.
108. Sessa, O.; Pagani, M. G.; Zurlo, D. E.; et al. Ann. Oncol. 1994, 5, 901
109. Ghielmini, M.; Bosshard, G.; Capolongo, L.; et al. Br. J. Cancer 1997, 75, 878.
110. Giovanni, B. P.; Italo, C.; Paolo, G.; et al. Bioorg. Med. Chem. 2004, 12, 3911.
111. Antonini, P.; Polucci, T. C.; Jenkins, L. R.; et al. J. Med. Chem. 1997, 40, 3749.
112. Antonini, P.; Polucci, A.; Magnano, S.; et al. J. Med. Chem. 2001, 44(20), 3329.
113. Sugaya, T.; Mimura, Y.; Shida, Y.; et al. J. Med. Chem. 1994, 37, 1028.
114. Capps, J.; Dunbar, S. R.; Kesten, J.; et al. J. Med. Chem. 1992, 35, 4770.